Immuno-Oncology Therapies: In-Depth Analysis of the Rapidly Evolving Landscape in Next-Generation Cancer Treatment

DUBLIN , March 20, 2024 /PRNewswire/ — The “Innovation Waves in Immuno-oncology Therapy Development” report has been added to ResearchAndMarkets.com’s offering.

Immuno-oncology (I-O) therapies target tumors by harnessing the host’s immune system. With the growing incidence and prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, including monoclonals, antibody-drug conjugates (ADCs), bispecific antibodies, and several therapeutic cancer vaccines, are making rapid strides in clinical trials as effective immunotherapy.

This study discusses the key trends and technologies driving the development of such I-O therapies. It delves into advancements in cancer vaccines and cell therapies for various cancer indications, highlighting some of the innovators in this space.

Next-generation cell therapies, personalized cancer vaccines, and strategic areas of focus have also been discussed in this report. The study examines the factors driving and restraining this industry and identifies the growth opportunities emerging from the changes in this space for market players and stakeholders to leverage.

Key questions answered in this study:

What does the current clinical landscape of I-O therapies look like?Which are the technology enablers driving the adoption of I-O therapies?What are the key developments in adoptive cell therapies and cancer vaccines?What are the roadblocks to successful translation?What are the research and development (R&D) focus areas?What are the key focus areas for the future?

Key Growth Opportunities

Growth Opportunity 1: Combination ImmunotherapiesGrowth Opportunity 2: Precision OncologyGrowth Opportunity 3: Advanced Synthetic Biology PlatformsGrowth Opportunity 4: Organoids and Organ-on-Chip Models

Key Topics Covered:

Growth Environment: I-O Therapies

Need for ImmunotherapyScope of AnalysisSegmentation: Snapshot of I-O TherapiesI-O Therapies in DevelopmentGrowth Opportunities in I-O TherapyGrowth DriversGrowth Restraints

Trends and R&D Focus: I-O Therapies

I-O Technology Trends and DevelopmentsTrends in I-O TherapeuticsTherapeutic Development Trends in I-OR&D Focus Areas to Boost ImmunotherapiesModulation of TME: Solid Tumor Type Determines TherapyDeveloping Effective Preclinical Models for TranslationStakeholders Developing Preclinical Models for I-O Therapy EvaluationHolistic Tumor Profiling to Boost Precision Oncology Efforts

Emerging I-O Therapeutic Modality Development Landscape

Quick Facts on I-O TherapiesClinical Development Landscape of I-O TherapiesCell Therapy to Create the Next Wave of I-O DevelopmentsCell Therapy Types: SnapshotClinical Development Landscape of I-O Cell TherapiesEmerging Areas of Focus to Improve Functionality and Safety Cell TherapiesNext-generation CAR-T Therapy DevelopmentPriority Areas to Improve the Accessibility of Cell ImmunotherapyInnovative Technologies for Cell Therapy Manufacturing and DeliveryStakeholders Developing Emerging Next-gen Cell TherapiesPotential of Vaccines to Address Challenges with Difficult-to-Treat CancersCancer Vaccine TypesPersonalized Neoantigen Vaccines in Clinical DevelopmentAreas of Focus to Bolster Cancer Vaccine DevelopmentRNA Vaccines to Drive the Wave of Prophylactic and Therapeutic Cancer VaccinesRoad Ahead for Cancer Vaccines and ImmunotherapyEmerging Cancer VaccineImpact of Emerging Cancer Vaccines Across Cancers

I-O Stakeholder Ecosystem

Regional Trends in I-O Developments and AdoptionFederal Initiatives and Programs Driving I-O Therapy DevelopmentI-O Deals and Investment TrendsNotable Partnerships and Collaborations in I-O, 2023

I-O Regulatory Environment and Reimbursement

I-O: Current Gaps and Potential OpportunitiesStrategies to Improve Access and Care Delivery of I-O Therapies

For more information about this report visit https://www.researchandmarkets.com/r/9og2f0

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/immuno-oncology-therapies-in-depth-analysis-of-the-rapidly-evolving-landscape-in-next-generation-cancer-treatment-302094453.html

SOURCE Research and Markets